TELA Bio (TELA) Non-Current Debt (2018 - 2026)

TELA Bio has reported Non-Current Debt for 8 years, with the latest figure at $55.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt rose 35.35% year-over-year to $55.9 million; the trailing twelve-month figure through Mar 2026 stood at $55.9 million (up 35.35% YoY), and the FY2025 full-year result was $55.7 million, up 35.33% from the prior year.
• Non-Current Debt for Q1 2026 stood at $55.9 million, roughly flat from $55.7 million in the prior quarter.
• The five-year high for Non-Current Debt was $55.9 million in Q1 2026, with the low at $38.1 million in Q2 2025.
• Average Non-Current Debt over 5 years is $42.3 million, with a median of $40.6 million recorded in 2023.
• Year-over-year, Non-Current Debt slipped 6.78% in 2025 and jumped 35.35% in 2026.
• Tracing TELA's Non-Current Debt over 5 years: stood at $39.9 million in 2022, then advanced by 1.5% to $40.5 million in 2023, then advanced by 1.5% to $41.1 million in 2024, then soared by 35.33% to $55.7 million in 2025, then gained by 0.38% to $55.9 million in 2026.
• The last three Non-Current Debt figures came in at $55.9 million (Q1 2026), $55.7 million (Q4 2025), and $41.5 million (Q3 2025), per Business Quant data.

Peer Comparison